13F filer · CIK 1858703
Blue Owl Capital Holdings LP
New York, NY · filing since Q4 2021 · last filing Aug 11, 2026
Reported value
$664.5M
+$292.3M vs prior
Positions
76
New / sold out
23 / 22
Added / reduced
11 / 13
Turnover
18.0%
buys $339.9M · sells $93.1M
Top-10 weight
78.5%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | SPACE EXPLORATION TECHN CORP | +1,398,815 | – | +$239.0M |
| New | CAPITAL ONE FINL CORP | +119,757 | – | +$24.0M |
| New | DEEP FISSION INC | +1,333,333 | – | +$14.7M |
| New | ARTIVA BIOTHERAPEUTICS INC | +874,542 | – | +$8.5M |
| Added | DELL TECHNOLOGIES INC | +19,062 | +137.1% | +$8.2M |
| Added | SAGIMET BIOSCIENCES INC | +926,667 | +277.5% | +$7.2M |
| New | COMPASS PATHWAYS PLC | +450,000 | – | +$6.4M |
| Added | LARIMAR THERAPEUTICS INC | +2,043,150 | +28.7% | +$6.2M |
| New | COMPASS PATHWAYS PLCCALL | +1,670,500 | – | +$5.2M |
| New | VIRIDIAN THERAPEUTICS INC | +260,000 | – | +$4.8M |
24 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | ENGENE HOLDINGS INC | -4,416,353 | -100.0% | $-30.1M |
| Reduced | MAPLIGHT THERAPEUTICS INC | -276,000 | -27.4% | $-9.9M |
| Reduced | CULLINAN THERAPEUTICS INC | -370,000 | -19.4% | $-6.7M |
| Sold out | COMPASS PATHWAYS PLC | -1,804,504 | -100.0% | $-5.1M |
| Sold out | CIVEO CORP CDA | -180,475 | -100.0% | $-4.8M |
| Sold out | KALVISTA PHARMACEUTICALS INC | -215,000 | -100.0% | $-4.3M |
| Sold out | OVID THERAPEUTICS INC | -1,904,666 | -100.0% | $-4.2M |
| Reduced | ULTRAGENYX PHARMACEUTICAL IN | -120,000 | -39.7% | $-4.0M |
| Sold out | PLIANT THERAPEUTICS INC | -2,969,199 | -100.0% | $-3.7M |
| Reduced | ELEDON PHARMACEUTICALS INC | -853,403 | -60.1% | $-3.4M |
25 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SPACE EXPLORATION TECHN CORPCLASS A COM STK | 1,398,815 | $239.0M | 35.97% |
| 2 | AKTIS ONCOLOGY INCCOM | 3,070,219 | $99.0M | 14.89% |
| 3 | CULLINAN THERAPEUTICS INCCOM | 1,539,764 | $28.0M | 4.22% |
| 4 | LARIMAR THERAPEUTICS INCCOM | 9,163,157 | $27.9M | 4.21% |
| 5 | NUVEEN CHURCHILL DIRECT LENDCOM SHS | 2,143,626 | $26.6M | 4.01% |
| 6 | MAPLIGHT THERAPEUTICS INCCOM | 729,929 | $26.2M | 3.94% |
| 7 | CAPITAL ONE FINL CORPCOM | 119,757 | $24.0M | 3.62% |
| 8 | BLUE OWL CAPITAL CORPORATIONCOM | 2,045,070 | $22.2M | 3.35% |
| 9 | DEEP FISSION INCCOM | 1,333,333 | $14.7M | 2.22% |
| 10 | DELL TECHNOLOGIES INCCL C | 32,961 | $14.2M | 2.14% |
66 more rows. Subscribe for $29/month to see every row, download the data and use the API.